Lubet RA - Search Results

1

Screening agents for preventive efficacy in a bladder cancer model: study design, end points, and gefitinib and naproxen efficacy.

Lubet RA, Steele VE, Juliana MM, Grubbs CJ. Lubet RA, et al. J Urol. 2010 Apr;183(4):1598-603. doi: 10.1016/j.juro.2009.12.001. Epub 2010 Feb 20. J Urol. 2010. PMID: 20172542

2

Targeting the insulin-like growth factor-1 receptor by picropodophyllin for lung cancer chemoprevention.

Zhang Q, Pan J, Lubet RA, Wang Y, You M. Zhang Q, et al. Among authors: lubet ra. Mol Carcinog. 2015 Jun;54 Suppl 1:E129-37. doi: 10.1002/mc.22206. Epub 2014 Aug 27. Mol Carcinog. 2015. PMID: 25163779

3

Short-term modulation of cell proliferation and apoptosis and preventive/therapeutic efficacy of various agents in a mammary cancer model.

Christov K, Grubbs CJ, Shilkaitis A, Juliana MM, Lubet RA. Christov K, et al. Among authors: lubet ra. Clin Cancer Res. 2007 Sep 15;13(18 Pt 1):5488-96. doi: 10.1158/1078-0432.CCR-07-0404. Clin Cancer Res. 2007. PMID: 17875779

4

Modulation of gene expression and cell-cycle signaling pathways by the EGFR inhibitor gefitinib (Iressa) in rat urinary bladder cancer.

Lu Y, Liu P, Van den Bergh F, Zellmer V, James M, Wen W, Grubbs CJ, Lubet RA, You M. Lu Y, et al. Among authors: lubet ra. Cancer Prev Res (Phila). 2012 Feb;5(2):248-59. doi: 10.1158/1940-6207.CAPR-10-0363. Epub 2011 Oct 7. Cancer Prev Res (Phila). 2012. PMID: 21982874

5

Preventive effects of bexarotene and budesonide in a genetically engineered mouse model of small cell lung cancer.

Wang Y, Wen W, Yi Y, Zhang Z, Lubet RA, You M. Wang Y, et al. Among authors: lubet ra. Cancer Prev Res (Phila). 2009 Dec;2(12):1059-64. doi: 10.1158/1940-6207.CAPR-09-0221. Epub 2009 Nov 24. Cancer Prev Res (Phila). 2009. PMID: 19934342 Free PMC article.

6

Effect of an epidermal growth factor receptor inhibitor in mouse models of lung cancer.

Yan Y, Lu Y, Wang M, Vikis H, Yao R, Wang Y, Lubet RA, You M. Yan Y, et al. Among authors: lubet ra. Mol Cancer Res. 2006 Dec;4(12):971-81. doi: 10.1158/1541-7786.MCR-06-0086. Mol Cancer Res. 2006. PMID: 17189387

7

Mouse models incorporating alterations in the major tumor suppressor genes P53 and P16: their use in screening for potential carcinogens, developing further relevant mouse models, and screening for potential chemopreventive and chemotherapetutic agents.

Lubet R, Wang Y, Zhang Z, You M. Lubet R, et al. Exp Lung Res. 2005 Jan-Feb;31(1):117-33. doi: 10.1080/01902140490495499. Exp Lung Res. 2005. PMID: 15765922 Review.

8

6-C-(E-phenylethenyl)-naringenin suppresses colorectal cancer growth by inhibiting cyclooxygenase-1.

Li H, Zhu F, Chen H, Cheng KW, Zykova T, Oi N, Lubet RA, Bode AM, Wang M, Dong Z. Li H, et al. Among authors: lubet ra. Cancer Res. 2014 Jan 1;74(1):243-52. doi: 10.1158/0008-5472.CAN-13-2245. Epub 2013 Nov 12. Cancer Res. 2014. PMID: 24220240 Free PMC article.

9

Lack of chemopreventive efficacy of metformin in rodent models of urinary bladder, head and neck, and colon/intestine cancer.

Thompson MD, Lubet RA, Mccormick DL, Clapper ML, Bode AM, Juliana MM, Moeinpour F, Grubbs CJ. Thompson MD, et al. Among authors: lubet ra. Oncol Lett. 2017 Sep;14(3):3480-3486. doi: 10.3892/ol.2017.6632. Epub 2017 Jul 20. Oncol Lett. 2017. PMID: 28927103 Free PMC article.

10

Daily or weekly dosing with EGFR inhibitors, gefitinib and lapatinib, and AKt inhibitor MK2206 in mammary cancer models.

Lubet RA, Steele VE, Juliana MM, Bode A, Moeinpour F, Grubbs CJ. Lubet RA, et al. Oncol Rep. 2018 Sep;40(3):1545-1553. doi: 10.3892/or.2018.6313. Epub 2018 Mar 14. Oncol Rep. 2018. PMID: 29565450 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results